Vaccines effective against severe disease, hospitalisation caused by Omicron: EMA

by IANS |

Brussels, Jan 12 (IANS) Citing preliminary data, the European Medicines Agency (EMA) has said that the Covid-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron coronavirus variant.

"Although Omicron appears to be more infectious than other variants, studies conducted in South Africa, the UK and some European Union (EU) member states show a lower risk of being hospitalised after infection with Omicron. Based on these studies, the risk is currently estimated to be between a third and half of the risk with the Delta variant," the EMA said on Tuesday in a release.

It cited results from recently published studies as showing that vaccine effectiveness against symptomatic disease is lower for Omicron than for other variants and tends to wane over time. As a result, more vaccinated people are likely to develop breakthrough disease due to Omicron.

However, these studies also show that vaccination continues to provide a high level of protection against severe disease and hospitalisation linked to the Omicron variant, Xinhua news agency reported.

The latest evidence, which includes real-world effectiveness data, also suggests that people who have had a booster dose are better protected than those who have only received their primary course.

The EMA's Head of Vaccines Strategy, Marco Cavaleri, said at a press conference on Tuesday that the agency continued to monitor the vaccines' effectiveness, and the outcome of this assessment may impact future vaccination strategies recommended by experts in the EU member states.

He added that having to take a booster dose every three or four months was not effective enough as a long-term strategy.

"We do not yet have data on the fourth dose to allow us to express ourselves, but we are concerned about a strategy that foresees going ahead with vaccinations in a short time," he said.

The EMA added in the statement that efforts should continue to increase full vaccination uptake in individuals who are currently unvaccinated or partially vaccinated and to accelerate the rollout of booster doses.

Latest News
Global Covid caseload tops 357.9 mn Wed, Jan 26, 2022, 11:42 AM
TN celebrates 73rd Republic Day with patriotic fervour Wed, Jan 26, 2022, 11:39 AM
Participants of Oslo talks call for understanding, cooperation on Afghanistan Wed, Jan 26, 2022, 11:36 AM
2nd ballot to elect Italy's Prez fails, but strong candidatures start emerging Wed, Jan 26, 2022, 11:29 AM
US House Speaker Pelosi announces reelection bid in 2022 midterms Wed, Jan 26, 2022, 11:29 AM
US warns of fragile semiconductor supply chain as chip inventory falls Wed, Jan 26, 2022, 11:28 AM
France reports new daily record of over 500,000 Covid-19 cases Wed, Jan 26, 2022, 11:27 AM
Ironic when nation recognizes Azad's services, Cong doesn't: Sibal Wed, Jan 26, 2022, 11:21 AM
TN to restore water bodies for recharging groundwater level Wed, Jan 26, 2022, 11:20 AM
Blackmailed on Instagram, man commits suicide in Karnataka Wed, Jan 26, 2022, 11:09 AM
Karnataka launches 'Brain Health Initiative' to help people beat Covid stress Wed, Jan 26, 2022, 11:07 AM
Rajpath brims over with patriotic fervour as India celebrates R-Day Wed, Jan 26, 2022, 11:06 AM
India's Tokyo Games heroes come together to recite National Anthem Wed, Jan 26, 2022, 11:05 AM
Afghanistan complete whitewash to grab crucial Cricket World Cup Super League points Wed, Jan 26, 2022, 11:02 AM
Kerala Minister unfurls Tricolour upside down in Kasargod Wed, Jan 26, 2022, 11:01 AM